Navigation Links
Combination vaccine protects monkeys from ebola and Marburg viruses
Date:2/26/2008

An experimental, combination vaccine against Ebola and Marburg viruses using virus-like particles (VLPs) provides complete protection against infection in monkeys. Researchers from the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) report their results today (Feb. 26) at the 2008 ASM Biodefense and Emerging Diseases Research Meeting in Baltimore, MD.

VLPs are one of the most promising candidates for protecting humans against Ebola and Marburg virus infections, says Dr. Kelly Warfield, a researcher at USAMRIID who presented the study. They could also be safer than other vaccine candidates.

Traditionally vaccines against viral diseases have consisted of whole viruses, either the one that causes the disease in a weakened or dead state (like the polio vaccine) or a genetically similar virus that does not usually cause disease but elicits a protective immune response. The problem with this approach is there is the risk, however small, of viral reactivation and infection.

Since the VLP vaccine does not use a whole virus, there is no chance of infection, says Warfield, who notes that some VLP-based vaccines, such as the human papillomavirus (HPV) vaccine, are already on the market.

To create the vaccine, Warfield and her colleagues infected insect cells with specially engineered baculoviruses. The infected cells then produced VLPs for either Marburg or Ebola, depending on the baculovirus, which were then purified. They mixed the two together and vaccinated the monkeys with it.

Following challenge with Ebola or Marburg virus, all the VLP-vaccinated monkeys survived challenge without clinical or laboratory signs of infection, while the control animals succumbed to the infection, says Warfield. Based on their safety profile, immunogenicity and protective efficacy, the VLPs are a leading candidate for use as a filovirus vaccine in humans.

Additionally, Warfield discovered that vaccinatio
'/>"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
Source:Eurekalert

Page: 1 2

Related biology technology :

1. New Phase III Data Demonstrate Oxycodone / Naloxone Combination Tablet Reduces Opioid-Induced Bowel Dysfunction in Patients With Chronic Severe Pain
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. DAIICHI SANKYO EUROPE is Applying for Approval of its New Combination Product of Olmesartan and Amlodipin
4. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
5. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
6. Genasense(R) Triple Combination Therapy in Advanced Melanoma Presented at Chemotherapy Foundation Symposium
7. Human Genome Sciences Initiates Second Randomized Phase 2 Trial of HGS-ETR1 in Combination With Chemotherapy
8. Oncolytics Biotech Inc. Completes Patient Enrolment in U.K. Phase Ia/Ib Combination REOLYSIN(R)/Radiation Clinical Trial
9. Oncolytics Biotech Inc. Announces Publication of Research on Combination Reovirus and Cyclophosphamide Treatment
10. FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy
11. Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...CORALVILLE, Iowa, Dec. 4 ...nfirmed that its shareholders of record on Decembe...ommon stock of HealthAmerica, Inc. that was previo...althAmerica is a private Nevada corporation of whi...ing common shares on the record date. The distribu...
(Date:12/3/2009)..., HOUSTON, Dec. 3 JourneyLite of... its facility to offer patients a second surgical ...the LAP-BAND® System that it currently perf...e facility was performed by surgeon partner, Matt...ent is reported as doing well. ,, The Vertical ...
(Date:12/3/2009)...HILADELPHIA, Dec. 3 Shir...ialty biopharmaceutical company, today announced a...t withdrawal of one lot of the Attention-Deficit/H... . Shire is taking this action because some Daytra...et their release liner removal specification, and ...
(Date:12/3/2009)... , NEW DELHI, India, Dec. 3 /PRNewswire-Asi...Officer at Shenzhen Beike Biotechnology Co. Ltd.,(...ence on High-Risk Diabetic,Foot Care in New Delhi,...g,stem cell research and regenerative medicine com...Indian Podiatry Association (IPA), aimed,to help p...
Breaking Biology Technology:Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3
...antonio, CIO at Lands, End, takes pride in his org...nd technology. "In a meeting you can,t separate th... collaborative spirit reaches all the way up and d...ecutive committee, which sets vision and strategic...picking and packing of orders in the warehouses. ...
..., Wis. Small Tree Communications , a niche hard...ple computers, has received a $445,000 funding rou... , ,"This [investment] is going to allow us to gro...arket sooner," said Corky Seeber, president of Sma...ice space and equipment, and to develop additional...
...k,s Tech Update, by WTN,s Mike Klein: The Wiscons...l of honor from the president for its contribution...s been acquired by a west-coast software firm. And...ted improved financial results for the past fiscal...005 Listen to this episode Read more about...
Other Biology Technology:Frank Giannantonio blends IT and business for Lands' End 2Frank Giannantonio blends IT and business for Lands' End 3Frank Giannantonio blends IT and business for Lands' End 4Chippewa Valley angels invest in network hardware company 2Chippewa Valley angels invest in network hardware company 3
(Date:12/3/2009)...c snowmelt that occurred during the 2008-09 austra...ive phases for two main climate drivers, ENSO (El ...sphere Annular Mode), according to Dr. Marco Tedes...ences at The City College of New York. , Profe...at the CUNY Graduate Center, added that Antarctic ...
(Date:12/2/2009)...strengthen the evidence that people who smoke ciga...d risk for developing colorectal cancer, even afte...vides one more reason not to smoke, or to quit as ...hun, M.D., M.S., vice president emeritus, epidemio...cer Society. "Colorectal cancer should be added to...
(Date:12/2/2009)...dolescents exposed to cigarette smoking scenes in ...lves, and this may be part of the acculturation pr...g to new study findings. , "Our study supports a...ghlights the global implementation of the World He...Control, which includes guidelines for countries t...
Breaking Biology News(10 mins):CCNY professor foresees rising Antarctic snowmelt 2Cigarette smoking increases colorectal cancer risk 2Watching movies featuring characters who smoke negatively influences Mexican-American teens 2Palatin Technologies Inc Reports First Quarter Fiscal Year 2010 Results 3B Teleconference and Webcast to be held on November 16 2009 14847 1Palatin Technologies Inc Reports First Quarter Fiscal Year 2010 Results 3B Teleconference and Webcast to be held on November 16 2009 14847 2Palatin Technologies Inc Reports First Quarter Fiscal Year 2010 Results 3B Teleconference and Webcast to be held on November 16 2009 14847 3Palatin Technologies Inc Reports First Quarter Fiscal Year 2010 Results 3B Teleconference and Webcast to be held on November 16 2009 14847 4Palatin Technologies Inc Reports First Quarter Fiscal Year 2010 Results 3B Teleconference and Webcast to be held on November 16 2009 14847 5Palatin Technologies Inc Reports First Quarter Fiscal Year 2010 Results 3B Teleconference and Webcast to be held on November 16 2009 14847 6Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference 14843 1Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference 14843 2Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 1Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 2Sleep Management Device Unit Sales to Grow at a Compound Annual Growth Rate of Over 16 25 as CMS Reimbursement Expands 6280 3
...physical and biological systems across the earth a...y humans, says a new analysis of information not p...n living things include earlier leafing of trees a...to higher latitudes and altitudes in the northern ...North America and Australia; and shifting of the o...
...w NASA-led study shows human-caused climate change...ural systems, including permafrost thawing, plants...ng in productivity in Africa. , Cynthia Rosenzwe...n New York and scientists at 10 other institutions... 1970 with rises in temperatures during that perio...
... the world,s top experts on evolution will gather ...8," the world,s largest annual gathering of evolut...ernational event for scientists to share research ...ty of Minnesota,s Bell Museum of Natural History, ...d Minnesota Citizens for Science Education. , Hea...
Other Biology News:Warming climate is changing life on global scale, says new study 2NASA study links Earth impacts to human-caused climate change 2University of Minnesota to host world's largest conference on evolution 2
Eppendorf Heat sealer for PCR plates from Sigma-Aldrich
Rabbit Anti-BMP2 Polyclonal Antibody, Unconjugated from GeneTex
Easy Pierce 20 m from ABgene
NucleoSpin Extract II from MACHEREY-NAGEL
Biology Products: